titanium has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, HJ; Keppler, B; Schmähl, D | 1 |
| Keppler, BK; Schmähl, D | 1 |
2 other study(ies) available for titanium and Carcinoma 256, Walker
| Article | Year |
|---|---|
Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Female; Organometallic Compounds; Rats; Time Factors; Titanium | 1982 |
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Cisplatin; Columbidae; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Organometallic Compounds; Rats; Sarcoma 180; Titanium | 1986 |